Press Release

• Revuforj^® (revumenib)
• Itovebi™ (inavolisib)
• Tevimbra^® (tislelizumab)
• LAZCLUZE^™ (lazertinib)
• Voranigo^® (vorasidenib)
• PIASKY^® (crovalimab)
• OJEMDA^™ (tovorafenib)
• Voydeya^™ (danicopan)
• Xpovio^® (selinexor)
• FABHALTA^® (iptacopan)